To the Editor: We believe that an important myositis-associated autoantibody, which could be of interest in the differential diagnosis, was overlooked by Drs. Korn and Mauiyyedi in their discussion of ...

– 7 of 8 myositis patients achieved clinically meaningful TIS responses after discontinuation of all immunomodulators, while off or actively tapering steroids; responses were sustained throughout the ...

Please provide your email address to receive an email when new articles are posted on . Autoimmune diseases may be easier to treat than cancers using cell therapy. Studies continue to examine its use ...

The anti-interleukin agent romilkimab showed significant benefits on skin fibrosis among patients with systemic sclerosis in a phase II trial, researchers reported. At week 24, the least squares mean ...

Methotrexate (MTX) can be used to control arthralgias in scleroderma (progressive systemic sclerosis, PSS) patients in a manner analogous to the use of MTX for rheumatoid arthritis and other ...

PHILADELPHIA, June 11, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell ...